1310383-42-6 Usage
General Description
5-Methyl-1H-indazole-6-boronic acid is a chemical compound with the molecular formula C8H10BNO2. It is a boronic acid derivative of indazole, a heterocyclic compound with a five-membered ring containing both nitrogen and carbon atoms. 5-Methyl-1H-indazole-6-boronic acid is commonly used in organic synthesis as a building block for the construction of more complex molecules, particularly in the field of medicinal chemistry. It is also used as a reagent in various chemical reactions, such as Suzuki coupling reactions, to form carbon-carbon bonds. Additionally, 5-Methyl-1H-indazole-6-boronic acid may have potential applications in the development of pharmaceuticals and agrochemicals, as well as in the study of biological processes related to boron-containing compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1310383-42-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,0,3,8 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1310383-42:
(9*1)+(8*3)+(7*1)+(6*0)+(5*3)+(4*8)+(3*3)+(2*4)+(1*2)=106
106 % 10 = 6
So 1310383-42-6 is a valid CAS Registry Number.
1310383-42-6Relevant articles and documents
Micromolecular reversible BTK inhibitor for treating rheumatoid arthritis
-
Paragraph 0140-0141; 0145-0148; 01490152, (2019/07/29)
The invention relates to a micromolecular reversible BTK inhibitor for treating rheumatoid arthritis, and specifically provides a compound. The compound is the compound as shown in a formula I, or a stereisomer, a geometrical isomer and a tautomer thereof, nitric oxide, aquo-complex, a solvate, a metabolite and pharmaceutically acceptable salts and prodrugs. The inventor finds that polysubstitutedquinolone compound or derivate thereof as shown in formula I can be used as the BTK inhibitor and is high in activity during treating rheumatoid arthritis.
